Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirodenafil for Erectile Dysfunction in Diabetic Patients
NCT00705861Phase 3Completed
- Sponsor
- SK Chemicals
- Start
- Nov 2007
- Primary completion
- Jul 2008
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) comparing Placebo with Mvix 100mg (2 arms). Primary endpoint: International Index of Erectile Function Erectile Function Domain Score at 12 weeks. Started Nov 2007; status: completed.
02
Drugs
mirodenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00705861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00705861.